Clinical Trial

Effectiveness of Genistein in Mild Cognitive Impairment

Study acronym: EXTRAGENIAL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Randomized, placebo-controlled, double-blind, multicenter clinical trial with two parallel study arms (experimental and placebo) to assess the efficacy of genistein extract consumption over 18 months on cognitive decline in patients with prodromal Alzheimer's disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-26.
Trial Details
NCT Number NCT07385937
Lead Sponsor Universidad Católica San Antonio de Murcia
Conditions Alzheimer Disease (AD), Mild Cognitive Impairment (MCI)
Enrollment 150 participants
Start Date 2026-02
Primary Completion 2027-07 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-17